# AstraZeneca Pharmaceuticals LP - Inspection Records

Source: https://www.keypedia.com/companies/astrazeneca-pharmaceuticals-lp/6f9abb75-9352-43df-b761-026089396fa3

> Inspection records and compliance data for AstraZeneca Pharmaceuticals LP in Frederick, Maryland. Access full analysis and detailed observations.

---

## Details

- Name: AstraZeneca Pharmaceuticals LP
- FEI Number: 3002617771
- City: Frederick
- State: Maryland
- Country Name: United States
- Address Line 1: 633 Research Dr
- Zip Code: 21703

## Related Documents

- [483 - AstraZeneca Pharmaceuticals LP - 2024-06-07](https://www.keypedia.com/records/483/astrazeneca-pharmaceuticals-lp/aea2bb99-1045-4587-8aea-e4bb1a016450) — source: FDA, date: June 7, 2024
- [483 - AstraZeneca Pharmaceuticals LP - 2024-06-07](https://www.keypedia.com/records/483/astrazeneca-pharmaceuticals-lp/6809d725-a3ed-4b2b-b0a2-b81cc7e01672) — source: FDA, date: June 7, 2024
- [483 - AstraZeneca Pharmaceuticals LP - 2024-06-07](https://www.keypedia.com/records/483/astrazeneca-pharmaceuticals-lp/f295582f-0d0d-456b-8a87-9c3c9acec931) — source: FDA, date: June 7, 2024
- [FDA Inspection 1242118 - AstraZeneca Pharmaceuticals LP - 2024-06-07](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/f2daf178-8dee-4d6c-b0d9-aad650939e87) — source: FDA, date: June 7, 2024
- [WARNING_LETTER - AstraZeneca Pharmaceuticals LP - 2023-08-15](https://www.keypedia.com/records/warning_letter/astrazeneca-pharmaceuticals-lp/ffb41aa4-e9b4-4e4e-b72f-9cf78acb857c) — source: FDA, date: August 15, 2023
- [483 - AstraZeneca Pharmaceuticals LP - 2023-01-19](https://www.keypedia.com/records/483/astrazeneca-pharmaceuticals-lp/05295a30-e31b-4220-a8bf-8906643f78cd) — source: FDA, date: January 19, 2023
- [FDA Inspection 1197584 - AstraZeneca Pharmaceuticals LP - 2023-01-19](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/8f38115c-8fc4-487e-a8a4-911759c96220) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 19, 2023
- [EIR - AstraZeneca Pharmaceuticals LP - 2021-03-19](https://www.keypedia.com/records/eir/astrazeneca-pharmaceuticals-lp/a9e01aea-4641-46b2-9417-2ecc9c9d80aa) — source: FDA, date: March 19, 2021
- [483 - AstraZeneca Pharmaceuticals LP - 2021-03-19](https://www.keypedia.com/records/483/astrazeneca-pharmaceuticals-lp/b308dbbf-6bee-4596-8859-b6320002a2e9) — source: FDA, date: March 19, 2021
- [FDA Inspection 1062666 - AstraZeneca Pharmaceuticals LP - 2018-08-17](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/e8cc1fea-3abb-4c6e-ba1a-26aa0b81097f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 17, 2018
- [FDA Inspection 936980 - AstraZeneca Pharmaceuticals LP - 2015-07-24](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/38f13f8b-b1dc-4dd9-92eb-01a857cfa3e2) — classification: No Action Indicated (NAI), source: FDA, date: July 24, 2015
- [FDA Inspection 800093 - AstraZeneca Pharmaceuticals LP - 2012-09-21](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/fde08717-9676-4f37-ab61-6645a32e4d4b) — classification: No Action Indicated (NAI), source: FDA, date: September 21, 2012
- [FDA Inspection 590281 - AstraZeneca Pharmaceuticals LP - 2009-06-18](https://www.keypedia.com/records/fda_inspections/astrazeneca-pharmaceuticals-lp/107a5153-cd5b-43fa-942e-545e1967efd0) — classification: No Action Indicated (NAI), source: FDA, date: June 18, 2009

## Related Companies

- [Biocon Biologics Limited](https://www.keypedia.com/companies/biocon-biologics-limited/d4e5402d-7d48-48ee-911b-8a78bfb97a67)
- [Torrent Pharmaceuticals Limited](https://www.keypedia.com/companies/torrent-pharmaceuticals-limited/801e26ba-26ed-40ab-84c9-d4ee2e24e42e)
- [MassBiologics South Coast](https://www.keypedia.com/companies/massbiologics-south-coast/bfed264e-18bc-497e-b0a8-29449b985350)
- [POINT Biopharma USA Inc.](https://www.keypedia.com/companies/point-biopharma-usa-inc/f4a8cb71-7a5c-4407-a6c8-6765aacfb8da)
- [Takeda Pharmaceutical Company Limited](https://www.keypedia.com/companies/takeda-pharmaceutical-company-limited/0f6bd1ca-94a2-41f0-a8dd-1af20069e6cf)
- [Celltrion Inc.](https://www.keypedia.com/companies/celltrion-inc/d3991ec8-423b-4554-9d67-72bc27a8658b)
- [Intas Pharmaceuticals Limited](https://www.keypedia.com/companies/intas-pharmaceuticals-limited/0db00702-d7f6-4a8b-87d1-1b32ac236cc8)
- [NerPharMa S.r.l.](https://www.keypedia.com/companies/nerpharma-srl/12f11f8a-e70e-4598-807c-a1571bab0391)
- [Gland Pharma Limited](https://www.keypedia.com/companies/gland-pharma-limited/dd730d79-1c97-4fb0-b717-c0ebd71a5b3f)
- [Juno Therapeutics, Inc.](https://www.keypedia.com/companies/juno-therapeutics-inc/d564709e-29d0-4aaf-9d68-efbf3cd67a35)

## Related Officers

- [Zhao Wang, Chemist, Ph.D.](https://www.keypedia.com/people/zhao-wang-chemist-phd/5c97ae2a-0968-4e26-8785-4854d8503d05)
- [Haohong Yan, Lead Chemist, Ph.D.](https://www.keypedia.com/people/haohong-yan-lead-chemist-phd/d0059cc8-8f07-4a82-8533-f920dca79017)
- [issuing_officer](https://www.keypedia.com/people/haoheng-yan/404af95d-404c-4227-b50e-544a96adc24a)
- [issuing_officer](https://www.keypedia.com/people/zhao-wang/51081e23-1891-4c93-9488-f578511e0a0e)
- [Sena G. Dissmeyer](https://www.keypedia.com/people/sena-g-dissmeyer/4dbb1255-95e4-402b-8bb3-75c4f7940c13)
- [Consumer Safety Officer ](https://www.keypedia.com/people/anastasia-m-shields/a22b8d52-e3f9-4e61-aa3f-6f03ff2f59df)